Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.

INTRODUCTION

Anti-glomerular basement membrane (anti-GBM) disease is a small vessel vasculitis affecting the renal and lung capillary beds. We aim to study the clinicopathological characteristics and predictors of poor outcome of this disease in our population.

MATERIALS AND METHODS

This is a 15 year retrospective, single center observational study of Indian cohort. Patients with biopsy proven anti-GBM disease were studied.

RESULTS

Anti-GBM disease was found in 0.5% of the total cases. The mean age at presentation was 46.7 years. Compared to renal limited disease those with pulmonary-renal syndrome had a higher frequency of hypertension, oliguria, percentage of crescents, interstitial inflammation and glomerulosclerosis. Double positive (anti-GBM and ANCA antibodies) patients showed more of glomerulosclerosis, tubular atrophy/interstitial fibrosis (IFTA) as well as periglomerular granulomas on biopsy. Patient survival at one year was 40.4% and death censored renal survival was 9.7%. Factors affecting the dialysis dependency at presentation were oligoanuria ( = .04), creatinine levels >5.7 mg/dl ( = .003), and high mean anti-GBM titers ( = .008). Atypical cases accounted for 8.3% of these patients. Oligoanuria (HR = 5.0,  = .05), high serum creatinine (HR = 1.55,  = .05), severe glomerulosclerosis (HR = 1.09,  = .03), and IFTA (HR = 2,  = .04) were associated with poor renal outcome. Advanced age (HR = 1.92,  = .03), high serum creatinine (HR = 1.9,  = .04) and high anti-GBM titers (HR = 1.01,  = .03) were associated with poor patient survival.

CONCLUSIONS

Anti-GBM is a rare disease with poor prognosis and varied presentations. Patients with pulmonary-renal syndrome showed severe disease whereas double positive had more of chronic changes. The predictors of poor prognosis include advanced age, oliguria, serum anti-GBM levels, serum creatinine levels, degree of glomerulosclerosis and IFTA. Atypical anti-GBM cases should be kept in mind while evaluating renal biopsies.